Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson's Disease.

Crabbé M, Van der Perren A, Bollaerts I, Kounelis S, Baekelandt V, Bormans G, Casteels C, Moons L, Van Laere K.

Front Neurosci. 2019 Jul 31;13:799. doi: 10.3389/fnins.2019.00799. eCollection 2019.

2.

Effect of postoperative haemoglobin variation on major cardiopulmonary complications in high cardiac risk patients undergoing anatomical lung resections.

Patella M, Mongelli F, Minerva EM, Previsdomini M, Perren A, Saporito A, La Regina D, Gavino L, Inderbitzi R, Cafarotti S.

Interact Cardiovasc Thorac Surg. 2019 Aug 13. pii: ivz199. doi: 10.1093/icvts/ivz199. [Epub ahead of print]

PMID:
31408170
3.

Non-invasive ventilation in palliative care. A narrative review.

Diaz de Teran T, Barbagelata E, Cilloniz C, Nicolini A, Perazzo T, Perren A, Ocak Serin S, Scharffenberg M, Fiorentino G, Zaccagnini M, El-Khatib MI, Pappadakos P, Karim HM, Solidoro P, Esquinas A.

Minerva Med. 2019 Jul 30. doi: 10.23736/S0026-4806.19.06273-6. [Epub ahead of print]

PMID:
31359741
4.

Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (NVUC).

Weyerer V, Weisser R, Moskalev EA, Haller F, Stoehr R, Eckstein M, Zinnall U, Gaisa NT, Compérat E, Perren A, Keck B, Allory Y, Kristiansen G, Wullich B, Agaimy A, Hartmann A, Bertz S.

Histopathology. 2019 Jul 26. doi: 10.1111/his.13958. [Epub ahead of print]

PMID:
31348552
5.

Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Dettmer MS, Schmitt A, Komminoth P, Perren A.

Pathologe. 2019 Jul 4. doi: 10.1007/s00292-019-0600-9. [Epub ahead of print] Review.

PMID:
31273418
6.

MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid Carcinoma.

Boos LA, Schmitt A, Moch H, Komminoth P, Simillion C, Marinoni I, Nikiforov YE, Nikiforova MN, Perren A, Dettmer MS.

Cancers (Basel). 2019 Jun 25;11(6). pii: E885. doi: 10.3390/cancers11060885.

7.

Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy.

Crabbé M, Van der Perren A, Kounelis S, Lavreys T, Bormans G, Baekelandt V, Casteels C, Van Laere K.

Exp Neurol. 2019 May 25;320:112964. doi: 10.1016/j.expneurol.2019.112964. [Epub ahead of print]

PMID:
31136763
8.

Persistent postdischarge pain and chronic postoperative pain after breast cancer surgery under general anesthesia and single-shot paravertebral block: incidence, characteristics and impact on quality of life and healthcare costs.

Saporito A, Aguirre J, Borgeat A, Perren A, Anselmi L, Poggi R, Minotti B, Cafarotti S, La Regina D, Ceruti S.

J Pain Res. 2019 Apr 16;12:1193-1199. doi: 10.2147/JPR.S195702. eCollection 2019.

9.

[Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].

Dettmer MS, Schmitt A, Komminoth P, Perren A.

Pathologe. 2019 May;40(3):227-234. doi: 10.1007/s00292-019-0613-4. Review. German.

PMID:
31093689
10.

ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.

Michael IP, Saghafinia S, Tichet M, Zangger N, Marinoni I, Perren A, Hanahan D.

Dev Cell. 2019 May 6;49(3):409-424.e6. doi: 10.1016/j.devcel.2019.04.015.

PMID:
31063757
11.

Severe rosuvastatin accumulation with rhabdomyolysis due to drug interactions and low cardiac output syndrome.

Previsdomini M, Graziano E, Decosterd L, Courlet P, Perren A, Ceschi A.

Br J Clin Pharmacol. 2019 Jul;85(7):1616-1618. doi: 10.1111/bcp.13950. Epub 2019 May 3. No abstract available.

PMID:
31050036
12.

Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.

Schürch CM, Roelli MA, Forster S, Wasmer MH, Brühl F, Maire RS, Di Pancrazio S, Ruepp MD, Giger R, Perren A, Schmitt AM, Krebs P, Charles RP, Dettmer MS.

Thyroid. 2019 Jul;29(7):979-992. doi: 10.1089/thy.2018.0555. Epub 2019 May 10.

13.

Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.

Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B.

Orphanet J Rare Dis. 2019 Feb 22;14(1):54. doi: 10.1186/s13023-019-1034-4.

14.

Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.

Peralta Ramos JM, Iribarren P, Bousset L, Melki R, Baekelandt V, Van der Perren A.

Front Immunol. 2019 Jan 29;10:80. doi: 10.3389/fimmu.2019.00080. eCollection 2019.

15.

Clinical Approaches to Assess Post-extubation Dysphagia (PED) in the Critically Ill.

Perren A, Zürcher P, Schefold JC.

Dysphagia. 2019 Aug;34(4):475-486. doi: 10.1007/s00455-019-09977-w. Epub 2019 Jan 25. Review.

PMID:
30684017
16.

A novel method to assess data quality in large medical registries and databases.

Perren A, Cerutti B, Kaufmann M, Rothen HU; Swiss Society of Intensive Care Medicine.

Int J Qual Health Care. 2019 Jan 4. doi: 10.1093/intqhc/mzy249. [Epub ahead of print]

PMID:
30608577
17.

Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.

Casadonte R, Kriegsmann M, Perren A, Baretton G, Deininger SO, Kriegsmann K, Welsch T, Pilarsky C, Kriegsmann J.

Proteomics Clin Appl. 2019 Jan;13(1):e1800046. doi: 10.1002/prca.201800046. Epub 2018 Dec 19.

PMID:
30548962
18.

Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.

Selberherr A, Koperek O, Riss P, Scheuba C, Kaderli R, Perren A, Niederle B.

Endocr Pathol. 2019 Mar;30(1):31-34. doi: 10.1007/s12022-018-9558-z.

19.

Implementation of modern tools in autopsy practice-the way towards contemporary postmortal diagnostics.

Langer R, Tröhler A, Schnüriger B, Trippel M, Blank A, Banz Y, Candinas D, Perren A, Lugli A.

Virchows Arch. 2019 Feb;474(2):149-158. doi: 10.1007/s00428-018-2482-2. Epub 2018 Nov 13.

PMID:
30426205
20.

Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S, Lawlor RT, Luong TV, Marinoni I, Panzuto F, Pape UF, Partelli S, Perren A, Rinzivillo M, Rubini C, Ruszniewski P, Scarpa A, Schmitt A, Schinzari G, Scoazec JY, Sessa F, Solcia E, Spaggiari P, Toumpanakis C, Vanoli A, Wiedenmann B, Zamboni G, Zandee WT, Zerbi A, Falconi M.

Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.

21.

Does spinal chloroprocaine pharmacokinetic profile actually translate into a clinical advantage in terms of clinical outcomes when compared to low-dose spinal bupivacaine? A systematic review and meta-analysis.

Saporito A, Ceppi M, Perren A, La Regina D, Cafarotti S, Borgeat A, Aguirre J, Van De Velde M, Teunkens A.

J Clin Anesth. 2019 Feb;52:99-104. doi: 10.1016/j.jclinane.2018.09.003. Epub 2018 Sep 18.

PMID:
30237085
22.

The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.

Sorbye H, Baudin E, Perren A.

Endocrinol Metab Clin North Am. 2018 Sep;47(3):683-698. doi: 10.1016/j.ecl.2018.05.001. Epub 2018 Jul 11. Review.

PMID:
30098724
23.

Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach.

Banz Y, Berezowska S, de Leval L, Rubbia-Brandt L, Tolnay M, Moch H, Perren A, Hewer E.

Virchows Arch. 2018 Nov;473(5):655-656. doi: 10.1007/s00428-018-2431-0. Epub 2018 Aug 7. No abstract available.

PMID:
30088082
24.

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.

Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ.

Hum Pathol. 2018 Dec;82:249-257. doi: 10.1016/j.humpath.2018.07.032. Epub 2018 Aug 3.

25.

The IGF pathway is activated in insulinomas but downregulated in metastatic disease.

Henfling M, Perren A, Schmitt AM, Saddig CM, Starke AA, Riedl RG, Versleijen-Jonkers YMH, Sprij-Mooij DM, Ramaekers FCS, Hofland L, Speel EM.

Endocr Relat Cancer. 2018 Jul 18. pii: ERC-18-0222. doi: 10.1530/ERC-18-0222. [Epub ahead of print]

26.

An unexpected blood thief: the subacute presentation of a spontaneous Ilio-iliac arterio-venous fistula.

Caranzano L, Colombo J, Cartolari R, Perren A.

Intensive Care Med. 2018 Nov;44(11):1953-1954. doi: 10.1007/s00134-018-5246-1. Epub 2018 Jun 12. No abstract available.

PMID:
29947881
27.

Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.

Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-Clarke R, Perren A, Lugli A, Toma M, Baretton G, Kristiansen G, Wirtz RM, Cheng L, Wullich B, Stoehr R, Hartmann A, Bertz S.

Hum Pathol. 2018 Oct;80:55-64. doi: 10.1016/j.humpath.2018.05.022. Epub 2018 Jun 6.

28.

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.

Gelders G, Baekelandt V, Van der Perren A.

J Immunol Res. 2018 Apr 16;2018:4784268. doi: 10.1155/2018/4784268. eCollection 2018. Review.

29.

Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation.

Janssen B, Vugts DJ, Wilkinson SM, Ory D, Chalon S, Hoozemans JJM, Schuit RC, Beaino W, Kooijman EJM, van den Hoek J, Chishty M, Doméné A, Van der Perren A, Villa A, Maggi A, Molenaar GT, Funke U, Shevchenko RV, Baekelandt V, Bormans G, Lammertsma AA, Kassiou M, Windhorst AD.

Sci Rep. 2018 Apr 26;8(1):6580. doi: 10.1038/s41598-018-24814-0.

30.

Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.

Krug S, Abbassi R, Griesmann H, Sipos B, Wiese D, Rexin P, Blank A, Perren A, Haybaeck J, Hüttelmaier S, Rinke A, Gress TM, Michl P.

Int J Cancer. 2018 Oct 1;143(7):1806-1816. doi: 10.1002/ijc.31562.

31.

Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.

Wartenberg M, Cibin S, Zlobec I, Vassella E, Eppenberger-Castori S, Terracciano L, Eichmann MD, Worni M, Gloor B, Perren A, Karamitopoulou E.

Clin Cancer Res. 2018 Sep 15;24(18):4444-4454. doi: 10.1158/1078-0432.CCR-17-3401. Epub 2018 Apr 16.

PMID:
29661773
32.

GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.

Li L, Zeng Q, Bhutkar A, Galván JA, Karamitopoulou E, Noordermeer D, Peng MW, Piersigilli A, Perren A, Zlobec I, Robinson H, Iruela-Arispe ML, Hanahan D.

Cancer Cell. 2018 Apr 9;33(4):736-751.e5. doi: 10.1016/j.ccell.2018.02.011. Epub 2018 Mar 29.

33.

Targeting Neuroinflammation to Treat Alzheimer's Disease.

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, Hoeijmakers L, Hoffmann A, Iaccarino L, Jahnert S, Kuhbandner K, Landreth G, Lonnemann N, Löschmann PA, McManus RM, Paulus A, Reemst K, Sanchez-Caro JM, Tiberi A, Van der Perren A, Vautheny A, Venegas C, Webers A, Weydt P, Wijasa TS, Xiang X, Yang Y.

CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3. Review.

34.

Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors.

Sadowski SM, Christ E, Bédat B, Kollár A, Karenovics W, Perren A, Triponez F; SwissNET registry.

Endocr Connect. 2018 Jan;7(1):8-15. doi: 10.1530/EC-17-0271. Epub 2017 Dec 11.

35.

Light in the dark: 18F-FDG PET/CT in Staphylococcus aureus bacteremia of unknown origin.

Colombo J, Elzi L, Treglia G, Perren A.

Intensive Care Med. 2018 Apr;44(4):488-489. doi: 10.1007/s00134-017-4994-7. Epub 2017 Nov 13. No abstract available.

PMID:
29134234
36.

Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.

Uccella S, Blank A, Maragliano R, Sessa F, Perren A, La Rosa S.

Endocr Pathol. 2017 Dec;28(4):351-361. doi: 10.1007/s12022-017-9505-4. Review.

PMID:
29063495
37.

Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.

Crabbé M, Van der Perren A, Weerasekera A, Himmelreich U, Baekelandt V, Van Laere K, Casteels C.

Neurobiol Aging. 2018 Jan;61:82-92. doi: 10.1016/j.neurobiolaging.2017.09.006. Epub 2017 Sep 21.

PMID:
29055799
38.

[Lean management in the pathology laboratory].

Blank A, Dawson H, Hammer C, Perren A, Lugli A.

Pathologe. 2017 Nov;38(6):540-544. doi: 10.1007/s00292-017-0388-4. German. No abstract available.

PMID:
29043447
39.

Dysphagia in Mechanically Ventilated ICU Patients (DYnAMICS): A Prospective Observational Trial.

Schefold JC, Berger D, Zürcher P, Lensch M, Perren A, Jakob SM, Parviainen I, Takala J.

Crit Care Med. 2017 Dec;45(12):2061-2069. doi: 10.1097/CCM.0000000000002765.

40.

Implementation of a 'lean' cytopathology service: towards routine same-day reporting.

Hewer E, Hammer C, Fricke-Vetsch D, Baumann C, Perren A, Schmitt AM.

J Clin Pathol. 2018 May;71(5):395-401. doi: 10.1136/jclinpath-2017-204504. Epub 2017 Sep 30.

PMID:
28974539
41.

Pathologie neuroendokriner Neoplasien: Angepasste Klassifikation, Gradierung und TNM Einteilung 2017: “Nomen est omen?”.

Grand M, Thielken A, Perren A, Komminoth P.

Ther Umsch. 2017 Sep;74(4):190-196. doi: 10.1024/0040-5930/a000903. Review. German. No abstract available.

PMID:
28950774
42.

Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and Paragangliomas.

Evenepoel L, van Nederveen FH, Oudijk L, Papathomas TG, Restuccia DF, Belt EJT, de Herder WW, Feelders RA, Franssen GJH, Hamoir M, Maiter D, Ghayee HK, Shay JW, Perren A, Timmers HJLM, van Eeden S, Vroonen L, Aydin S, Robledo M, Vikkula M, de Krijger RR, Dinjens WNM, Persu A, Korpershoek E.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):46-55. doi: 10.1210/jc.2017-01314.

PMID:
28938490
43.

Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism.

Wiedmer T, Blank A, Pantasis S, Normand L, Bill R, Krebs P, Tschan MP, Marinoni I, Perren A.

Mol Cancer Ther. 2017 Nov;16(11):2502-2515. doi: 10.1158/1535-7163.MCT-17-0136. Epub 2017 Jul 20.

44.

Genetic and epigenetic drivers of neuroendocrine tumours (NET).

Di Domenico A, Wiedmer T, Marinoni I, Perren A.

Endocr Relat Cancer. 2017 Sep;24(9):R315-R334. doi: 10.1530/ERC-17-0012. Epub 2017 Jul 14. Review.

PMID:
28710117
45.

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.

Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H.

Eur J Surg Oncol. 2017 Sep;43(9):1682-1689. doi: 10.1016/j.ejso.2017.04.010. Epub 2017 May 4.

PMID:
28522174
46.

Androgen production in pediatric adrenocortical tumors may occur via both the classic and/or the alternative backdoor pathway.

Marti N, Malikova J, Galván JA, Aebischer M, Janner M, Sumnik Z, Obermannova B, Escher G, Perren A, Flück CE.

Mol Cell Endocrinol. 2017 Sep 5;452:64-73. doi: 10.1016/j.mce.2017.05.014. Epub 2017 May 10.

PMID:
28501574
47.

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers.

Oberg K, Couvelard A, Delle Fave G, Gross D, Grossman A, Jensen RT, Pape UF, Perren A, Rindi G, Ruszniewski P, Scoazec JY, Welin S, Wiedenmann B, Ferone D; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):201-211. doi: 10.1159/000472254. Epub 2017 Apr 8. No abstract available.

48.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.

Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense RT, Kulke M, Oeberg K, Rindi G, Sorbye H, Welin S; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):196-200. doi: 10.1159/000457956. Epub 2017 Feb 11. No abstract available.

49.

Hypo-methylation mediates chromosomal instability in pancreatic NET.

Marinoni I, Wiederkeher A, Wiedmer T, Pantasis S, Di Domenico A, Frank R, Vassella E, Schmitt A, Perren A.

Endocr Relat Cancer. 2017 Mar;24(3):137-146. doi: 10.1530/ERC-16-0554. Epub 2017 Jan 23.

50.

TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.

Brügger F, Dettmer MS, Neuenschwander M, Perren A, Marinoni I, Hewer E.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):61-66. doi: 10.1093/jnen/nlw106.

PMID:
28040793

Supplemental Content

Loading ...
Support Center